FDA Inspection 1109991 — Lingraphicare America, Inc.

Lingraphicare America, Inc. — FEI 1000123978

The FDA completed an inspection of Lingraphicare America, Inc. on Nov 15, 2019 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 15, 2019
Fiscal Year
2020
Product Type
Devices
Project Area
Compliance: Devices
Location
Princeton, NJ (United States)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472221 CFR 820.40Procedures not adequately established or maintained
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
312721 CFR 820.80(e)Documentation
313021 CFR 820.100(a)Lack of or inadequate procedures
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.